The pulmonary artery catheter market size has grown steadily in recent years. It will grow from $1.26 billion in 2025 to $1.32 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to growth in critical care admissions, adoption in cardiac surgeries, advancement in ICU monitoring, clinician familiarity with PACs, increased cardiovascular disease burden.
The pulmonary artery catheter market size is expected to see steady growth in the next few years. It will grow to $1.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to demand for advanced hemodynamic data, growth in complex ICU cases, technological improvements in catheter design, expansion of critical care infrastructure, emerging economies healthcare growth. Major trends in the forecast period include shift toward minimally invasive hemodynamic monitoring, increased use in high-risk cardiac procedures, rising preference for disposable catheters, focus on accuracy and safety enhancements, decline in routine use in low-risk patients.
The increasing incidence of lung diseases is increasingly supporting the expansion of the pulmonary artery catheter market going forward. Lung diseases affect the respiratory system and impair the lungs’ ability to exchange oxygen and carbon dioxide effectively. The rising incidence of lung diseases is strongly linked to increasing air pollution, as prolonged exposure to harmful pollutants damages lung tissue and contributes to chronic respiratory conditions. Pulmonary artery catheters are used to assess heart and lung function by measuring pressures within the pulmonary artery, aiding in the diagnosis and management of complex cardiopulmonary conditions. For example, in May 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the age-adjusted prevalence of diagnosed chronic obstructive pulmonary disease among adults aged 18 years and older was 3.8%, with higher prevalence observed among women than men. As a result, the growing incidence of lung diseases is strengthening demand for pulmonary artery catheters.
Leading companies operating in the pulmonary artery catheter market are developing innovative products, such as endovascular catheters, to improve the accuracy of hemodynamic monitoring, enhance patient safety, and support minimally invasive assessment of cardiac function and pulmonary pressures. An endovascular catheter is a specialized medical device used to access and monitor the pulmonary artery. For example, in January 2024, Thrombolex Inc., a US-based medical device company, launched the BASHIR.035 and BASHIR S-B endovascular catheters for the treatment of acute pulmonary embolism. These catheters feature an expandable infusion basket that enables targeted thrombolysis by delivering thrombolytic agents directly into the clot, facilitating rapid restoration of blood flow, reducing procedure time, and improving patient safety.
In September 2024, Becton, Dickinson and Company, a US-based medical device company, acquired Edwards Lifesciences Inc. for an undisclosed amount. This acquisition is designed to strengthen BD’s critical care product portfolio and reinforce its position in advanced patient monitoring solutions. Edwards Lifesciences Inc. is a US-based medical device company specializing in heart valve technologies, hemodynamic monitoring, and critical care solutions.
Major companies operating in the pulmonary artery catheter market are Cardinal Health Corp, Medtronic Inc, Becton Dickinson And Company, Philips Healthcare Corp, Boston Scientific Corporation, Medline Industries Inc, B Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Smiths Medical Group, Teleflex Incorporated, Merit Medical Systems Inc, Vygon SA, ICU Medical Inc, Argon Medical Devices Inc, Biosensors International Group Ltd, Getinge AB, Osypka Medical GmbH, Pulsion Medical Systems SE, Cook Medical.
North America was the largest region in the pulmonary artery catheter market in 2025. The regions covered in the pulmonary artery catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonary artery catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pulmonary artery catheter market by raising costs of imported catheter components and pressure sensors, impacting hospitals and ICUs in North America and Asia-Pacific. High-end multi-lumen catheters face greater pricing pressure. On the positive side, tariffs are accelerating local production, supplier diversification, and cost-efficient catheter innovations.
The pulmonary artery catheter market research report is one of a series of new reports that provides pulmonary artery catheter market statistics, including pulmonary artery catheter industry global market size, regional shares, competitors with a pulmonary artery catheter market share, detailed pulmonary artery catheter market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary artery catheter industry. This pulmonary artery catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A pulmonary artery catheter (PAC) is a specialized catheter used to measure pressures within the heart and pulmonary arteries. It supplies essential information about cardiovascular function, particularly in critically ill patients, and is commonly used in intensive care to monitor cardiac output, pulmonary pressures, and other hemodynamic measurements.
The primary products in pulmonary artery catheters include four-lumen, five-lumen, six-lumen artery catheters, and others. A four-lumen artery catheter is a medical device featuring four separate channels to support functions such as hemodynamic monitoring, medication administration, and blood sampling. These devices are used in intensive care units (ICUs), non-intensive care settings, and other clinical environments, including hospitals, long-term care facilities, and others.
The pulmonary artery catheter market consists of sales of swan-ganz catheters, heparin-bonded catheters, multi-lumen catheters, temperature-sensing catheters, and pressure monitoring catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pulmonary artery catheter market size is expected to see steady growth in the next few years. It will grow to $1.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to demand for advanced hemodynamic data, growth in complex ICU cases, technological improvements in catheter design, expansion of critical care infrastructure, emerging economies healthcare growth. Major trends in the forecast period include shift toward minimally invasive hemodynamic monitoring, increased use in high-risk cardiac procedures, rising preference for disposable catheters, focus on accuracy and safety enhancements, decline in routine use in low-risk patients.
The increasing incidence of lung diseases is increasingly supporting the expansion of the pulmonary artery catheter market going forward. Lung diseases affect the respiratory system and impair the lungs’ ability to exchange oxygen and carbon dioxide effectively. The rising incidence of lung diseases is strongly linked to increasing air pollution, as prolonged exposure to harmful pollutants damages lung tissue and contributes to chronic respiratory conditions. Pulmonary artery catheters are used to assess heart and lung function by measuring pressures within the pulmonary artery, aiding in the diagnosis and management of complex cardiopulmonary conditions. For example, in May 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the age-adjusted prevalence of diagnosed chronic obstructive pulmonary disease among adults aged 18 years and older was 3.8%, with higher prevalence observed among women than men. As a result, the growing incidence of lung diseases is strengthening demand for pulmonary artery catheters.
Leading companies operating in the pulmonary artery catheter market are developing innovative products, such as endovascular catheters, to improve the accuracy of hemodynamic monitoring, enhance patient safety, and support minimally invasive assessment of cardiac function and pulmonary pressures. An endovascular catheter is a specialized medical device used to access and monitor the pulmonary artery. For example, in January 2024, Thrombolex Inc., a US-based medical device company, launched the BASHIR.035 and BASHIR S-B endovascular catheters for the treatment of acute pulmonary embolism. These catheters feature an expandable infusion basket that enables targeted thrombolysis by delivering thrombolytic agents directly into the clot, facilitating rapid restoration of blood flow, reducing procedure time, and improving patient safety.
In September 2024, Becton, Dickinson and Company, a US-based medical device company, acquired Edwards Lifesciences Inc. for an undisclosed amount. This acquisition is designed to strengthen BD’s critical care product portfolio and reinforce its position in advanced patient monitoring solutions. Edwards Lifesciences Inc. is a US-based medical device company specializing in heart valve technologies, hemodynamic monitoring, and critical care solutions.
Major companies operating in the pulmonary artery catheter market are Cardinal Health Corp, Medtronic Inc, Becton Dickinson And Company, Philips Healthcare Corp, Boston Scientific Corporation, Medline Industries Inc, B Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Smiths Medical Group, Teleflex Incorporated, Merit Medical Systems Inc, Vygon SA, ICU Medical Inc, Argon Medical Devices Inc, Biosensors International Group Ltd, Getinge AB, Osypka Medical GmbH, Pulsion Medical Systems SE, Cook Medical.
North America was the largest region in the pulmonary artery catheter market in 2025. The regions covered in the pulmonary artery catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonary artery catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pulmonary artery catheter market by raising costs of imported catheter components and pressure sensors, impacting hospitals and ICUs in North America and Asia-Pacific. High-end multi-lumen catheters face greater pricing pressure. On the positive side, tariffs are accelerating local production, supplier diversification, and cost-efficient catheter innovations.
The pulmonary artery catheter market research report is one of a series of new reports that provides pulmonary artery catheter market statistics, including pulmonary artery catheter industry global market size, regional shares, competitors with a pulmonary artery catheter market share, detailed pulmonary artery catheter market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary artery catheter industry. This pulmonary artery catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A pulmonary artery catheter (PAC) is a specialized catheter used to measure pressures within the heart and pulmonary arteries. It supplies essential information about cardiovascular function, particularly in critically ill patients, and is commonly used in intensive care to monitor cardiac output, pulmonary pressures, and other hemodynamic measurements.
The primary products in pulmonary artery catheters include four-lumen, five-lumen, six-lumen artery catheters, and others. A four-lumen artery catheter is a medical device featuring four separate channels to support functions such as hemodynamic monitoring, medication administration, and blood sampling. These devices are used in intensive care units (ICUs), non-intensive care settings, and other clinical environments, including hospitals, long-term care facilities, and others.
The pulmonary artery catheter market consists of sales of swan-ganz catheters, heparin-bonded catheters, multi-lumen catheters, temperature-sensing catheters, and pressure monitoring catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pulmonary Artery Catheter Market Characteristics
3. Pulmonary Artery Catheter Market Supply Chain Analysis
4. Global Pulmonary Artery Catheter Market Trends and Strategies
5. Pulmonary Artery Catheter Market Analysis of End Use Industries
7. Global Pulmonary Artery Catheter Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pulmonary Artery Catheter Total Addressable Market (TAM) Analysis for the Market
9. Pulmonary Artery Catheter Market Segmentation
10. Pulmonary Artery Catheter Market Regional and Country Analysis
11. Asia-Pacific Pulmonary Artery Catheter Market
12. China Pulmonary Artery Catheter Market
13. India Pulmonary Artery Catheter Market
14. Japan Pulmonary Artery Catheter Market
15. Australia Pulmonary Artery Catheter Market
16. Indonesia Pulmonary Artery Catheter Market
17. South Korea Pulmonary Artery Catheter Market
18. Taiwan Pulmonary Artery Catheter Market
19. South East Asia Pulmonary Artery Catheter Market
20. Western Europe Pulmonary Artery Catheter Market
21. UK Pulmonary Artery Catheter Market
22. Germany Pulmonary Artery Catheter Market
23. France Pulmonary Artery Catheter Market
24. Italy Pulmonary Artery Catheter Market
25. Spain Pulmonary Artery Catheter Market
26. Eastern Europe Pulmonary Artery Catheter Market
27. Russia Pulmonary Artery Catheter Market
28. North America Pulmonary Artery Catheter Market
29. USA Pulmonary Artery Catheter Market
30. Canada Pulmonary Artery Catheter Market
31. South America Pulmonary Artery Catheter Market
32. Brazil Pulmonary Artery Catheter Market
33. Middle East Pulmonary Artery Catheter Market
34. Africa Pulmonary Artery Catheter Market
36. Pulmonary Artery Catheter Market Competitive Landscape and Company Profiles
37. Pulmonary Artery Catheter Market Other Major and Innovative Companies
40. Pulmonary Artery Catheter Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pulmonary Artery Catheter Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pulmonary artery catheter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pulmonary artery catheter? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary artery catheter market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Four Lumen Artery Catheter; Five Lumen Artery Catheter; Six Lumen Artery Catheter; Other Product Types2) By Application: Intensive Care Units (ICUs); Non-Intensive Care Units (ICUs); Other Applications
3) By Model Of Delivery: Hospitals; Long Term Care Facilities; Other End Users
Subsegments:
1) By Four Lumen Artery Catheter: Standard Four Lumen Catheter; Thermodilution Four Lumen Catheter; Specialty Four Lumen Catheter2) By Five Lumen Artery Catheter: Standard Five Lumen Catheter; Thermodilution Five Lumen Catheter; Specialty Five Lumen Catheter
3) By Six Lumen Artery Catheter: Standard Six Lumen Catheter; Thermodilution Six Lumen Catheter; Specialty Six Lumen Catheter
4) By Other Product Types: Introducer Sheath Catheters; Pressure Monitoring Catheters; Specialty Catheters; Disposable Pulmonary Artery Catheters
Companies Mentioned: Cardinal Health Corp; Medtronic Inc; Becton Dickinson And Company; Philips Healthcare Corp; Boston Scientific Corporation; Medline Industries Inc; B Braun Melsungen AG; Terumo Corporation; Edwards Lifesciences Corporation; Nipro Corporation; Smiths Medical Group; Teleflex Incorporated; Merit Medical Systems Inc; Vygon SA; ICU Medical Inc; Argon Medical Devices Inc; Biosensors International Group Ltd; Getinge AB; Osypka Medical GmbH; Pulsion Medical Systems SE; Cook Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pulmonary Artery Catheter market report include:- Cardinal Health Corp
- Medtronic Inc
- Becton Dickinson And Company
- Philips Healthcare Corp
- Boston Scientific Corporation
- Medline Industries Inc
- B Braun Melsungen AG
- Terumo Corporation
- Edwards Lifesciences Corporation
- Nipro Corporation
- Smiths Medical Group
- Teleflex Incorporated
- Merit Medical Systems Inc
- Vygon SA
- ICU Medical Inc
- Argon Medical Devices Inc
- Biosensors International Group Ltd
- Getinge AB
- Osypka Medical GmbH
- Pulsion Medical Systems SE
- Cook Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.32 Billion |
| Forecasted Market Value ( USD | $ 1.58 Billion |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
